Acta Oncologica, Volume 61, Issue 9 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Acta Oncologica, Volume 61, Issue 9 (2022)

See all volumes and issues
Vol 62, 2023 Volume 61, 2022 Vol 60, 2021 Vol 59, 2020 Vol 58, 2019 Vol 57, 2018 Vol 56, 2017 Vol 55, 2016 Vol 54, 2015 Vol 53, 2014 Vol 52, 2013 Vol 51, 2012 Vol 50, 2011 Vol 49, 2010 Vol 48, 2009 Vol 47, 2008 Vol 46, 2007 Vol 45, 2006 Vol 44, 2005 Vol 43, 2004 Vol 42, 2003 Vol 41, 2002 Vol 40, 2001 Vol 39, 2000 Vol 38, 1999 Vol 37, 1998 Vol 36, 1997 Vol 35, 1996 Vol 34, 1995 Vol 33, 1994 Vol 32, 1993 Vol 31, 1992 Vol 30, 1991 Vol 29, 1990 Vol 28, 1989 Vol 27, 1988 Vol 26, 1987 Vol 25, 1986 Vol 24, 1985 Vol 23, 1984 Vol 22, 1983 Vol 21, 1982 Vol 20, 1981 Vol 19, 1980 Vol 18, 1979 Vol 17, 1978 Vol 16, 1977 Vol 15, 1976 Vol 14, 1975 Vol 13, 1974 Vol 12, 1973 Vol 11, 1972 Vol 10, 1971 Vol 9, 1970 Vol 8, 1969 Vol 7, 1968 Vol 6, 1967 Vol 5, 1966 Vol 4, 1966 Vol 3, 1965 Vol 2, 1964 Vol 1, 1963
Download citations Download PDFs Download issue

Editorial

Editorial
Watch your steps, especially when changing treatment for locally advanced rectal cancer
Olav Dahl
Pages: 1033-1035
Published online: 09 Nov 2022
First Page PreviewforWatch your steps, especially when changing treatment for locally advanced rectal cancer | Full Text | References | PDF (304.2 KB) | EPUB
  • 646 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Articles: Clinical Oncology

Article
Reasons for lack of treatment in patients with locally advanced, unresectable or metastatic urothelial carcinoma
Lise H. Omland, Ulla N. Joensen, Birgitte G. Toft, Cecilia M. Lund, Henriette Lindberg, Mark B. Knudsen, Anders Tolver, Charlotte Suetta & Helle Pappot
Pages: 1036-1042
Published online: 25 Aug 2022
AbstractforReasons for lack of treatment in patients with locally advanced, unresectable or metastatic urothelial carcinoma | Full Text | References | PDF (785.5 KB) | EPUB
  • 623 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Symptoms and diagnosis of local recurrence after rectal cancer treatment
Sophia Waldenstedt, Eva Haglind & Eva Angenete
Pages: 1043-1049
Published online: 13 Aug 2022
AbstractforSymptoms and diagnosis of local recurrence after rectal cancer treatment | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1179 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints—a cohort study
Tejasvini Vaid, Mukul Aggarwal, Jasmita Dass, Rishi Dhawan, Pradeep Kumar, Ganesh Kumar Viswanathan, Seema Tyagi, Tulika Seth & Manoranjan Mahapatra
Pages: 1050-1055
Published online: 11 Aug 2022
AbstractforShifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints—a cohort study | Full Text | References | PDF (653.7 KB) | EPUB | Supplemental
  • 498 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma
Karin Nielsen, Maja Vestmoe Maraldo, Anne Kiil Berthelsen, Annika Loft, Peter de Nully Brown, Ivan Richter Vogelius, Peter Meidahl Petersen & Lena Specht
Pages: 1056-1063
Published online: 14 Sep 2022
AbstractforPatterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 376 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors
Talya Salz, Emily C. Zabor, Peter De Nully Brown, Susanne Oksbjerg Dalton, Nirupa J. Raghunathan, Matthew J. Matasar, Richard Steingart, Henrik Hjalgrim, Lena Specht, Andrew J. Vickers, Kevin C. Oeffinger & Christoffer Johansen
Pages: 1064-1068
Published online: 18 Oct 2022
AbstractforCardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 646 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer
Megi Gjini, Sadia Ahmed, Shalom Kalnicki, Wolfgang A. Tomé, Madhur K. Garg, Rafi Kabarriti & N. Patrik Brodin
Pages: 1069-1074
Published online: 17 Aug 2022
AbstractforVolumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 541 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis
Caryn Wujanto, Tabitha Y. Chan, Yu Yang Soon & Balamurugan Vellayappan
Pages: 1075-1083
Published online: 02 Sep 2022
AbstractforShould adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 771 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Reviews: Clinical Oncology

Review
The importance of measuring baseline tumour volume (or alternatively tumour length along with its rectal circumferential extent) in the watch-and-wait strategy in rectal cancer: a review
Anna Hołdakowska, Jean-Pierre Gerard & Krzysztof Bujko
Pages: 1084-1092
Published online: 15 Sep 2022
AbstractforThe importance of measuring baseline tumour volume (or alternatively tumour length along with its rectal circumferential extent) in the watch-and-wait strategy in rectal cancer: a review | Full Text | References | PDF (906.2 KB) | EPUB | Supplemental
  • 680 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Review
Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review
Freya A. Bastrup, Mille Vissing & Julie Gehl
Pages: 1093-1104
Published online: 27 Aug 2022
AbstractforElectrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review | Full Text | References | PDF (1.5 MB) | EPUB
  • 1611 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review
Efficacy and safety of PD-1/PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis
Meilin Zhang, Jian Song, Hongguang Yang, Feng Jin & Ang Zheng
Pages: 1105-1115
Published online: 08 Aug 2022
AbstractforEfficacy and safety of PD-1/PD-L1 inhibitors in triple-negative breast cancer: a systematic review and meta-analysis | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 1678 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Letters to the Editor: Clinical Oncology

Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy
Fernanda Costa Svedman, Marie Jalsenius, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Samuel Rotstein, Lars Ny, Suzanne Egyhazi Brage & Hildur Helgadottir
Pages: 1116-1120
Published online: 09 Sep 2022
First Page PreviewforDynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1222 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
The utility of short-course radiotherapy in a watch-and-wait strategy for rectal cancer – the need to measure the interval to tumour response assessment from the radiation start
Lucyna Pietrzak, Anna Cencelewicz, Andrzej Rutkowski, Anna Hołdakowska, Karol Paciorek, Michał Jankowski, Wojciech Zegarski, Joanna Reszke, Przemysław Wawok, Piotr Richter, Krzysztof Małecki, Jolanta Szelachowska, Marek Bębenek, Iwona Gisterek, Malgorzata Jankiewicz, Wojciech Michalski, Joanna Socha, Agnieszka Zółciak-Siwińska, Krzysztof Bujko & for the Polish Colorectal Study Group
Pages: 1121-1125
Published online: 06 Oct 2022
First Page PreviewforThe utility of short-course radiotherapy in a watch-and-wait strategy for rectal cancer – the need to measure the interval to tumour response assessment from the radiation start | Full Text | References | PDF (488.3 KB) | EPUB | Supplemental
  • 1455 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma – diagnostic and therapeutic dilemma
Alicja Sadowska-Klasa, Mary Abba, Justyna Gajkowska-Kulik & Jan Maciej Zaucha
Pages: 1126-1131
Published online: 06 Jun 2022
First Page PreviewforTherapy-related acute lymphoblastic leukemia following treatment for multiple myeloma – diagnostic and therapeutic dilemma | Full Text | References | PDF (855.8 KB) | EPUB | Supplemental
  • 1502 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Hypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study
Anna Cecilie Lefèvre, Jan Alsner, Brita Singers Sørensen, Trine Tramm, Kasper Toustrup, Jens Overgaard & Karen-Lise Garm Spindler
Pages: 1132-1135
Published online: 22 Jun 2022
First Page PreviewforHypoxia and local tumour control in squamous cell carcinoma of the anus – a hypothesis-generating study | Full Text | References | PDF (1.1 MB) | EPUB
  • 819 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
Sarah Glewis, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie & Michael Michael
Pages: 1136-1139
Published online: 16 Aug 2022
First Page PreviewforPharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial | Full Text | References | PDF (533.1 KB) | EPUB | Supplemental
  • 1400 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma
Aymeric Hennemann, Marie Agnès Collonge Rame, Eve Puzenat, Cécile Ged, Sylvain Harbon, François Aubin & Charlée Nardin
Pages: 1140-1142
Published online: 11 Aug 2022
First Page PreviewforEfficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma | Full Text | References | PDF (622.1 KB) | EPUB
  • 903 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study
Vanita Noronha, Anuradha Chougule, Pratik Chandrani, Rajiv Kumar Kaushal, Vijay Maruti Patil, Nandini Menon, Akhil Kapoor, Sunil Chopade, Ajaykumar Singh, Omshree Shetty, Amit Dutt, Shripad Banavali & Kumar Prabhash
Pages: 1143-1147
Published online: 16 Aug 2022
First Page PreviewforLung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study | Full Text | References | PDF (640.3 KB) | EPUB | Supplemental
  • 1920 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Patterns of care in oligometastatic disease: the clinicians’ perspective
M. van Overeem Felter, M. Josipovic, E. Serup-Hansen, P. F. Geertsen, C. F. Behrens, A. A. Khalil & G. F. Persson
Pages: 1148-1151
Published online: 25 Aug 2022
First Page PreviewforPatterns of care in oligometastatic disease: the clinicians’ perspective | Full Text | References | PDF (885.9 KB) | EPUB | Supplemental
  • 708 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol
Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen & Karen-Lise Garm Spindler
Pages: 1152-1156
Published online: 12 Sep 2022
First Page PreviewforOPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol | Full Text | References | PDF (887.8 KB) | EPUB
  • 1229 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data
Jiasheng Wang, Srilatha Dasari, Dina Elantably, Akram Alkrekshi & Yeseong David Kim
Pages: 1157-1161
Published online: 29 Sep 2022
First Page PreviewforUse of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data | Full Text | References | PDF (687.3 KB) | EPUB | Supplemental
  • 2372 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles